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Abstract 
Parvovirus B19  is  a  widespread  virus  with  diverse  clinical  presentations.    The viral  non-
structural protein, NS1, binds to and cleaves the viral genome, and induces apoptosis when 
t r a n s f e c t e d   i n t o   n o n p e r m i s s i v e   c e l l s ,   s u c h   a s   h e p a t o c y t e s .     W e   h y p o t h e s i z e d   t h a t   t h e   c y t o-
t o x i c i t y   o f   N S 1   i n   s u c h   c e l l s   r e s u l t s   f r o m   c h r o m o s o m a l   D N A   d a m a g e   c a u s e d   b y   t h e  
DNA-nicking and DNA-attaching activities of NS1.  Upon testing this hypothesis, we found 
t h a t   N S 1   c o v a l e n t l y   b i n d s   t o   c e l l u l a r   D N A   a n d   i s   m o d i f i e d   b y   P A R P ,   a n   e n z y m e   i n v o l v e d   i n  
repairing single-stranded DNA nicks.  We furthermore discovered that the DNA nick repair 
pathway initiated by poly(ADPribose)pol y m e r a s e   a n d   t h e   D N A   r e p a i r   p a t h w a y s   i n i t i a t e d   b y  
ATM/ATR are necessary for efficient apoptosis resulting from NS1 expression. 
Key words: Parvovirus B19, DNA damage and repair, fulminant liver failure, apoptosis, autoan-
tibody, systemic lupus erythematosus 
Introduction 
Parvovirus B19 (B19) is a common  virus  with 
multiple clinical presentations.  Infection in children is 
typically  seen  as  erythema  infectiosum, or  fifth  dis-
ease  (1),  while  adults  often  experience  arthropathy 
lasting up to several months (2).  Autoantibodies are 
often found subsequent to B19 infection, and are as-
sociated  with  arthropathy  (3-5).    In  patients  with 
chronic hemolytic anemias, such as sickle cell disease 
or  hereditary  spherocytosis,  the  destruction  of  the 
erythroid precursor pool by B19 leads to aplastic crisis 
(6).  B19 infection is implicated in hepatitis non-A-E 
acute fulminant liver failure (7-16).    Although  these 
are the best-described clinical illnesses caused by B19, 
the virus has been implicated i n   a   w i d e   s p e c t r u m   o f  
other illnesses (17).  
B 1 9   i n f e c t s   a   v a r i e t y   o f   c e l l   t y p e s ,   b u t   p r e d o m i-
nantly replicates in erythroid precursors (18).     I n f e c-
tion  of  other  cell  types  results  in  a  limited, 
non-r e p l i c a t i v e   s t a t e   w i t h   o v e r e x p r e s s i o n   o f   t h e   v i r a l  
nonstructural  protein,  NS1,  and  little  expression  of 
genes  for  the  structural  proteins  VP1  and  VP2  (19).  
P r e v i o u s   w o r k   i n   o u r   l a b o r a t o r y   s h o w e d   t h a t   B 1 9   i s  
capable of infecting liver cells, and that the resulting 




through the action of NS1 (19, 20).     N S 1   i s   c y t o t o x i c  
when transfected into erythroid cells (21), COS-7 cells 
(22) and liver-derived cells (20).     I n   c e l l   t y p e s   w h i c h  
are  non-productive  for  viral  infection,  NS1-induced 
apoptosis proceeds in a caspase 9-dependent manner, 
indicative of internal apoptotic stimuli (20, 22).   
T h e   N S 1   p r o t e i n   o f   p a r v o v i r u s   B 1 9   e x h i b i t s   m u l-
tiple functions, with NTP binding, helicase, nickase, 
and transcription factor activities (23-25).     B e c a u s e   o f  
these  DNA-modifying  activities,  we  hypothesized 
that  NS1  induces  apoptosis  by  damaging  cellular 
D N A .     A p o p t o s i s   r e s u l t i n g   f r o m   D N A   d a m a g e   w o u l d  
be consistent with the caspase-9-dependent apoptotic 
pathway (20, 22).   
This  hypothesis  is  supported  by  the  action  of 
N S 1   p r o t e i n s   f r o m   s i m i l a r   p a r v o v i r u s e s .     T h e   n o n-
s t r u c t u r a l   p r o t e i n s   f r o m   t h e   p a r v o v i r u s e s   m i n u t e   v i-
r u s   o f   m o u s e   ( M V M )   a n d   H -1 parvovirus also utilize 
helicase  and  DNA  binding  activities  to  fulfill  their 
functions in viral replication (26-29).     N S 1   f r o m   M V M  
binds  cova l e n t l y   t o   t h e   v i r a l   g e n o m e   a s   p a r t   o f   t h e  
replication process (29,  30).     I n   a d d i t i o n ,   N S 1   f r o m  
MVM and H-1   p a r v o v i r u s   c o l o c a l i z e s   w i t h   t h e   c e l l u l a r  
DNA repair machinery (31-33).  Covalent attachment 
to cellular DNA would cause a significant lesion, as 
would  the  introduction  of  multiple  single-strand 
br e a k s .     D N A   d a m a g e   d u e   t o   t h e   a c t i o n s   o f   N S 1  
w o u l d   b e   e x p e c t e d   t o   r e s u l t   i n   a p o p t o s i s   i n   a   p o r t i o n  
of infected cells. 
This study utilized cloned NS1 under the control 
of an inducible promoter to examine the mechanisms 
of  NS1-i n d u c e d   a p o p t o s i s .     T h e   N S 1   D N A  sequence 
w a s   f u s e d   t o   t h a t   o f   g r e e n   f l u o r e s c e n t   p r o t e i n   ( G F P )  
(http://tools.invitrogen.com/content/sfs/vectors/pi
ndsp1gfp.pdf) to allow visualization and purification 
o f   N S 1   ( G F P / N S 1 ) .     C e l l u l a r   e x p r e s s i o n   o f   t h i s   v e c t o r  
has previously been shown to induce   a p o p t o s i s   i n   t h e  
same manner as infection with natural B19, while a 
m u t a n t   o f   N S 1   w i t h   t h e   N T P   b i n d i n g   r e g i o n   d e l e t e d  
induced  significantly  less  apoptosis  (20).     T h e  
G F P / N S 1   v e c t o r   w a s   u t i l i z e d   i n   t h i s   s t u d y   t o   i n v e s-
tig a t e   t h e   r o l e   o f   t h e   D N A -damaging activities of NS1 
in NS1-induced apoptosis.  
There  are  several  mechanisms  through  which 
N S 1   c o u l d   c a u s e   D N A   d a m a g e   r e s u l t i n g   i n   a p o p t o s i s .    
We hypothesized that NS1 could covalently attach to 
chromosomal DNA, in much the same way that the 
nonstructural proteins of MVM and H-1 parvovirus 
attach  to  the  viral  genome.    Covalent  attachment  of 
N S 1   t o   c e l l u l a r   D N A   w a s   i n v e s t i g a t e d   i n   t h i s   s t u d y  
using  denaturing  SDS-PAGE  and  autoradiography.  
A t t a c h m e n t   o f   N S 1   t o   D N A   w o u l d   b e   e x p e c ted  to 
initiate  the  DNA  repair  pathways  that  sense  distor-
t i o n s   i n   t h e   D N A   h e l i x .     T h e s e   p a t h w a y s   w e r e   e x-
amined by inhibition of the key proteins ataxia telan-
giectasia  related  (ATR)  and  ataxia  telangiecta-
sia-m u t a t e d   ( A T M ) .     T h e   D N A -nicking activity that 
NS1  u s e s   t o   s e p a r a t e   v i r a l   g e n o m e s   w o u l d   b e   e x-
pected to activate the single-s t r a n d   b r e a k   D N A   r e p a i r  
pathway if applied to host cell DNA.  This pathway 
was  investigated  by  studying  the  activity  of 
Poly(ADP-ribose)Polymerase  (PARP),  the  protein 
which detects nicks in DNA and activates the repair 
process.  
B o t h   t h e   n i c k   r e p a i r   a n d   A T R / A T M -mediated 
bulky adduct repair pathways can result in apoptosis 
i f   t h e   d a m a g e   i s   s e v e r e .     D a m a g e   o f   c h r o m o s o m a l  
D N A   b y   p a r v o v i r a l   p r o t e i n s   h a s   n o t   b e e n   d i r e c t l y  
demonstrated,  excep t   i n   t h e   c a s e   o f   s p e c i f i c   i n t e g r a-
tion of AAV.  We present here evidence suggesting 
t h a t   N S 1   i s   a t t a c h e d   t o   D N A   i n   a   c o v a l e n t   m a n n e r ,  
and that both DNA-helix distorting and single strand 
n i c k   f o r m s   o f   D N A   d a m a g e   a r e   i m p o r t a n t   p a t h w a y s  
to apoptosis upon expression of NS1. 
Materials and Methods 
Transfection 
A   G F P / N S 1   e x p r e s s i o n   v e c t o r   u n d e r   t h e   c o n t r o l  
o f   t h e   e c d y s o n e   r e s p o n s e   e l e m e n t   p r e v i o u s l y   c o n-
s t r u c t e d   i n   o u r   l a b o r a t o r y   w a s   u t i l i z e d   f o r   t h e s e   e x-
periments  as  previously  described  (20).    Briefly, 
H e p G 2   c e l l s   w e r e   g r o w n   o n   g l a s s   c o v e r s l i p s   i n   h e p a-
tocyte wash medium (Invitrogen, Carlsbad, CA) sup-
plemented  with  10%  fetal  calf  serum.    Either 
GFP/NS1 or the parental vector, pIND(GFP)SP1 (In-
vitrogen) was cotransfected with the ecdysone recep-
tor plasmid pVGRXR (Invitrogen) into the cells using 
Lipofectamine (Invitrogen) and  PLUS  reagent  (Invi-
trogen).  Expression of GFP/NS1 or GFP was induced 
b y   t h e   a d d i t i o n   o f   1 0   µ g / m l   p o n a s t e r o n e   A   ( I n v i t r o-
gen).  Protein expression was monitored by fluores-
cence microscopy. 
Immunoprecipitation and chromatin immunoprecipitation 
Cells express i n g   e i t h e r   G F P / N S 1   o r   G F P   w e r e  
l y s e d   w i t h   1 %   S D S   i n   T E   b u f f e r .     T h e   l y s a t e   w a s   c e n-
trifuged  through  a  Qiashredder  (Qiagen,  Valencia 
C A )   t o   s h e a r   D N A .     L y s a t e s   w e r e   t h e n   m i x e d   w i t h   2  
m l   o f   1 %   t r i t o n -X   1 0 0   ( F i s h e r ,   H a m p t o n ,   N H )   i n   P B S  
containing  protease  inhibitors (Sigma protease inhi-
bitor cocktail, Sigma-A l d r i c h ,   S t .   L o u i s ,   M O ) .     2 5   μ l   o f  
anti-GFP  polyclonal  antibody  (Rockland,  Gilberts-
ville, PA) were added and the mixture was allowed to 
b i n d   f o r   1 4   h o u r s   a t   4 oC  in  an  end-over end rotator.  
Immune complexes w e r e   b o u n d   t o   p r o t e i n   G -agarose 
beads  (Pierce,  Rockford,  IL)  for  three  hours  at  4oC.  
Immunoprecipitates were washed 5x with 1% triton-X 




minutes  under  reducing  conditions  in  1%  SDS,  4M 
urea and 0.7 M 2-mercaptoethanol.  Immunoprecipi-
tates were electrophoresed on a 7.5-14%  polyacryla-
mide gel and used for autoradiography and Western 
blotting. 
For  chromatin  immunoprecipitation,  107  cells 
w e r e   c o t r a n s f e c t e d   w i t h   p V G R X R   a n d   e i t h e r  
G F P / N S 1   o r   p I N D ( G F P ) S P 1 .     P rotein expression was 
induced  with  ponasterone  A  24  hours 
post-transfection and the cellular DNA was metabol-
ically labeled with 10 µCui α32P  thymidine  triphos-
phate  (Perkin  Elmer)  in  supplemented  hepatocyte 
wash medium (Invitrogen).  After immunoprecipita-
tion,  one  aliquot  of  each  immunoprecipitate  was 
treated with 10 units DNase (Roche) for 1 hour at 
37oC .     A f t e r   S D S -PAGE, proteins were transferred to 
n i t r o c e l l u l o s e   a n d   u s e d   t o   e x p o s e   K o d a k   M S   f i l m   t o  
obtain  an  autoradiograph  image.    GFP  antibodies 
were then used to identify the location of the trans-
genic protein by Western Blotting.  
Western blotting 
H e p G 2   c e l l s   w e r e   l y s e d   i n   1 %   ( w / v )   S D S ,   4 M  
urea  and  0.7M  2-mercaptoethanol.    Lysates  were 
electrophoresed  through  7.5-14%  acrylamide  gels 
(BioRad, Hercules, CA).  Proteins were transferred to 
nitrocellulose  membranes and  bound with  anti-GFP 
polyclonal rabbit antiserum (Invitrogen) or poly(ADP 
ribose) (PAR) monoclonal antibody (Pharmingen, San 
D i e g o ,   C A )   a t   1 : 5 0 0 0   d i l u t i o n .     S p e c i e s -specific sec-
ondary antibodies (Amersham, Piscataway, NJ) were 
used  for  detection  with  ECL+  chemiluminescence 
(Amersham).  
 Detection of apoptosis 
Transfected  HepG2  cells  were  grown  on  glass 
coverslips  and  stained  with  annexin-V-Alexa  fluor 
594  (Molecular  Probes,  Eugene,  OR)  as  previously 
described (19,  20).  Transfected cells were identified 
by  green  fluorescence  and  examined  for  apoptosis 
using a 528-553 nm excitation filter and a 600-660 nm 
b a r r i e r   f i l t e r   t o   a l l o w   f o r   d e t e c t i o n   o f   t h e  
red-fluorescing  apoptosis  marker.    Apoptotic  cells 
also  exhibited  condensed  nuclei  when stained with 
Hoescht 33342 (Molecular Probes). 
Treatment with pharmacologic agents 
Transfected HepG2 cells were pretreated with 8 
t o   1 4   m M   c a f f e i n e   ( S i g m a )   f o r   3   h o u r s   b e f o r e   i n d u c-
t i o n   o f   p r o t e i n   e x p r e s s i o n .     C a f f e i n e   w a s   m a i n t a i n e d  
on the cells during ex p r e s s i o n   o f   G F P   o r   G F P / N S 1 .    
PARP  was  inhibited  by  incubating  transfected  cells 
with 5-aminoisoquinolinone (Calbiochem) at 250, 25, 
2 . 5 ,   a n d   0 . 2 5   μ M   c o n c e n t r a t i o n s   3   h o u r s   p r i o r   t o  
transgene induction.  The inhibitor was maintained on 
the cells throughout the experiment. 
Statistical Analysis 
The student’s T test (2-tailed) was used to eva-
luate  significant  differences  in  the  experiments  in-
volving  inhibition  of  apoptosis,  and  the  Pearson’s 
correlation test was used to determine whether inhi-
bition was dose-dependent.  P values of less than 0.05 
were considered significant. 
Results 
Covalent attachment of NS1 to chromosomal DNA 
Association of NS1 with chromosomal DNA was 
detected  using  chromatin  immunoprecipitation.  
HepG2 cells were transfected with the GFP/NS1 ex-
pression vector or GFP vector alone and metabolically 
labeled with  32P-thymidine  triphosphate  during  the 
protein expression phase of the experiment.  Labeled 
DNA was detected by autoradiography and proteins 
were detected by Western blotting.  Radioactivity was 
f o u n d   i n   s p e c i f i c   b a n d s   t h a t   p e r f e c t l y   o v e r l a p p e d   w i t h  
b a n d s   f o r m e d   b y   G F P / N S 1 ,   b u t   n o t   G F P ,   a s   r e v e a l e d  
by Western blotting (Figure 1).  The colocalization of 
t h e   r a d i o a c t i v e   s i g n a l   w i t h   N S 1   s h o w s   t h a t   D N A   i s  
b o u n d   t o   N S 1   i n   t h e   l y s a t e .     T h e   h a r s h   denaturing 
methods used both in the immunoprecipitation and in 
t h e   p r e p a r a t i o n   o f   t h e   s a m p l e s   f o r   S D S -PAGE 
s t r o n g l y   s u g g e s t   t h a t   D N A   c o u l d   n o t   h a v e   b e e n  
present with the NS1 fusion protein unless covalently 
linked.    Treatment  of  the  immunoprecipitate  with 
DNase before SDS-PAGE decreased the radiographic 
signal by 63%, indicating that the radioactive label is 
D N A ,   a n d   n o t   f r o m   a n o t h e r   s o u r c e   s u c h   a s   p h o s p h o-
rylation of NS1 (Figure 1).   
Involvement of the DNA damage repair pathway 
D N A   d a m a g e   n o r m a l l y   b l o c k s   progression 
through  the  cell  cycle  and,  when  severe,  causes 
apoptosis  through  the  intrinsic  or  mitochondrial 
p a t h w a y .     C a f f e i n e   u n c o u p l e s   D N A   d a m a g e   f r o m   c e l l  
cycle  progression  and  apoptosis,  primarily  through 
the  inhibition  of  the  DNA  damage  sensing  protein 
ATM and ATR, (34, 35).  The involvement of the DNA 
d a m a g e   r e p a i r   p a t h w a y   i n   N S 1 -induced  apoptosis 
w a s   e x a m i n e d   i n   G F P / N S 1 -transfected cells by treat-
i n g   t h e   c e l l s   w i t h   c a f f e i n e .     I ncubation  of 
GFP/NS1-transfected  cells  with  caffeine  inhibited 
apoptosis in a dose-dependent manner, reducing the 
percentage of apoptotic cells by nearly 70% at a con-






F i g u r e   1 .     D N A   i s   c o v a lently bound to NS1 protein.  A. Autoradiography of GFP-immunoprecipitated 
32P labeled 
c e l l s   s h o w s   r a d i o a c t i v e   D N A   c o l o c a l i z i n g   w i t h   G F P / N S 1   ( 1 0 0   k d ) ,   b u t   n o t   G F P   a l o n e   ( 3 7   k d ) ,   a f t e r   b o i l i n g   i n   S D S   w i t h   u r e a  
and β-mercaptoethanol.  GFP and GFP/NS1 were detected by western blot.  The blot shown is representative of 4 inde-
pendent experiments.  B. Incubation of immunoprecipitates with DNase before the denaturation step abrogates the ra-
diographic signal by 63% (N=3 experiments, error bars indicate the range).   
 
F i g u r e   2 .     T h e   A T M / A T R -mediated DNA repair pathways are necessary for efficient NS1-induced apopto-
sis.     A. Caffeine treatment of GFP/NS1-transfected HepG2 cells led to a decrease in apoptosis of up to 63%, indicating the 
necessity for ATR-dependent activity in apoptosis.  The decrease in apoptotic caffeine-treated cells compared to cells 
without caffeine treatment was significant by the student’s t test for the three concentrations.  Pearson correlation analysis 
comparing caffeine dose to apoptosis showed that the inhibition was dose-dependent (p<0.041).  The data were derived 





No  difference  was  observed  in  apoptosis  be-
tween the GFP-transfected cells and the untransfected 
c e l l s   u p o n   t r e a t m e n t   w i t h   c a f f e i n e .     T h e   d e c r e a s e   i n  
apoptosis upon treatment with caffeine supports the 
finding  that  NS1  induces  apoptosis  through  DNA 
damage that alters the chromatin structure. 
Involvement of the DNA nick repair pathway 
Although  the  ATM/ATR-dependent  DNA  re-
pair pathway is important in optimal NS1-induced 
apoptosis, NS1 may also activate other DNA damage 
repair  pathways  that  can  lead  to  apoptosis.    Sin-
gle-s t r a n d   n i c k s   i n   g e n o m i c   D N A   w o u l d   b e   e x p e c t e d  
to activate PARP and the nick repair pathway.  Acti-
v a t e d   P A R P   t r a n s f e r s   P o l y ( A D P   r i b o s e )   ( P A R )   t o  
neighboring  proteins   i n   r e s p o n s e   t o   D N A   d a m a g e  
(36-38).     A s   a   m e t h o d   of investigating the involvement 
of  PARP  activation  in  NS1-induced  apoptosis,  the 
NS1 fusion protein was examined for the presence of 
activated  PAR  moieties,  which  would  indicate  the 
presence of NS1 in a DNA lesion that was sufficient to 
activate PARP, as well as demonstrating that the two 
molecules, NS1 and PARP were in physical contact.  
GFP/NS1  or  GFP  alone  were  immunoprecipitated 
f r o m   t r a n s f e c t e d   c e l l s ,   a n d   w e s t e r n   b l o t t i n g   w a s   p e r-
formed using an anti-P A R   a n t i b o d y .     G F P / N S 1   w a s  
poly(ADP ribose)ylated, while GFP was not (Figure 
3A).  Poly(ADP ribose)ylation of NS1 shows that NS1 
exists in the cell in contact with activated PARP, and 
hence, in the presence of sufficient DNA nicks to ac-
t i v a t e   t h i s   r e p a i r   p a t h w a y .     T o   s t u d y   t h e   i m p o r t a n c e  
o f   t h e   P A R P -initiated  DNA  repair  pathway  in 
NS1-induced  apoptosis,  the  cell-permeable  PARP 
inhibitor 5-aminoisoquinolinone (5AIQ) was added to 
GFP/NS1-transfected  HepG2  cells.    Inhibition  of 
PARP  significantly  (p<0.003)  reduced  apoptosis  in 
these cells compared to treatment with  DMSO  alone 
(Figure 3B).  Inhibition of apoptosis was maximal at 
5 7 %   a t   a   c o n c e n t r a t i o n   o f   2 5   µ M .     T h i s   f i n d i n g   d e-
monstrates  that  PARP  activation,  and  therefore  the 
PARP-i n d u c e d   D N A   r e p a i r   p a t h w a y ,   i s   a n   i m p o r t a n t  
mechanism of NS1-induced apoptosis.   
 
Figure 3.  PARP is active and necessary for efficient 
apoptosis in NS1-transfected cells.  A. Immunopreci-
pitated GFP/NS1 protein was poly(ADP ribose)ylated, as 
s h o w n   b y   a   b a n d   a t   1 0 0   k d   o n   t h e   b l o t   p r o b e d   w i t h   a n t i -poly 
ADP ribose (PAR, left blot) antibodies.  The blots were 
stripped and reprobed with anti-GFP (right), showing that 
PAR colocalizes with the GFP/NS1 fusion protein.  GFP 
a l o n e   i s   n o t   r i b o s y l a t e d ,   a s   e v i d e n c e d   b y   t h e   l a c k   o f   a   P A R  
band corresponding to GFP at 37 kD.  Blots shown are 
representative of three independent experiments.  B. PARP 
activity  is  necessary  for  optimal  NS1-induced  apoptosis.  
Addition  of  the  PARP  inhibitor  5-aminoisoquinolinone 
(5AIQ)  to  GFP/NS1  expressing  HepG2  cells  reduced 
apoptosis  by  57%  (p<0.003).    Addition  of 
5-aminoisoquinolinone had no effect on the GFP trans-
fected cells.  N=3, error bars indicate the range of values. 
Discussion 
This  work  identifies  several  lines  of  evidence 
indicating that NS1 damages cellular DNA, and that 
t h i s   d a m a g e   l e a d s   t o   a p o p t o s i s .     U p o n   d e tection  of 
D N A   d a m a g e ,   D N A   d a m a g e   r e s p o n s e   p r o t e i n s   i n h i-
b i t   t h e   c e l l   c y c l e   a n d   a r e   c a p a b l e   o f   i n d u c i n g   a p o p t o s i s  
if the DNA lesion is not repaired.  Several of these 
repair  pathways  involve  the  DNA  damage  sensing 




ATM phosphorylate a variety of substrates, including 
CHK-1 ,   p 5 3 ,   a n d   p 7 3 ,   e a c h   o f   w h i c h   f u r t h e r   t r a n s-
d u c e s   s i g n a l s   t h a t   r e s u l t   i n   D N A   r e p a i r   o r   a p o p t o s i s  
(39, 40).     B l o c k a g e   o f   t h e   c e l l   c y c l e   h a s   b e e n   n o t e d   i n  
B19 and other parvovirus infected cells (21, 33, 41, 42), 
and p53 was implicated in NS1-induced apoptosis of 
COS-7 cells (22).     T h e s e   e a r l i e r   f i n d i n g s   s u g g e s t   t h a t  
N S 1   m a y   i n d u c e   t h e s e   D N A   r e p a i r   m e c h a n i s m s .     T h e  
experiments  in  this  study  are  consistent  with 
ATR/ATM-m e d i a t e d   D N A   r e p a i r   b e i n g   i m p o r t a n t   f o r  
parvovirus  B19  NS1  protein-induced  apoptosis.    In-
hibition of ATR and ATM with caffeine (34) substan-
t i a l l y   d e c r e a s e d   t h e   a m o u n t   o f   a p o p tosis observed in 
the NS1-expressing cells.  Although there are limita-
tions inherent in these methods, the results presented 
a r e   s u g g e s t i v e   o f   D N A   d a m a g e   a s   a   c a u s e   o f  
NS1-induced  apoptosis.    ATM  principally  binds  to 
free DNA ends or DNA strand breaks (43), while ATR 
recognizes single-stranded regions of DNA common 
to multiple types of DNA lesions and that are often 
c a u s e d   b y   c o l l a p s e d   r e p l i c a t i o n   f o r k s   (44).     N S 1   c o u l d  
e a s i l y   c a u s e   d o u b l e   s t r a n d   b r e a k s   t h r o u g h   t h e   s i m p l e  
mechanism of nicking bot h   D N A   s t r a n d s   a   s h o r t   d i s-
tance  apart.    Nicking  and  binding  to  the  DNA  end 
w o u l d   n o t   o n l y   c r e a t e   b r o k e n   s t r a n d s ,   b u t   a d d u c t s  
that  would  likely  interrupt  replication  and  activate 
ATR-dependent DNA damage repair and apoptosis. 
The  pathway  responsible  for  the repair of sin-
gle-strand  nicks  in  DNA  is  also  important  for 
NS1-i n d u c e d   a p o p t o s i s .     T h i s   p a t h w a y   i s   m e d i a t e d  
through  PARP.    Upon  binding  DNA  nicks,  PARP 
t r a n s f e r s   p o l y ( A D P   r i b o s e )   ( P A R )   c h a i n s   t o   m a n y   o f  
the surrounding proteins, leading to DNA repair and 
a decrease in the ATP levels of the cell (37, 38).     I f   t h e  
d a m a g e   t o   t h e   D N A   i s   e x t e n s i v e ,   b o t h   t h e   a d d u c t   r e-
pair and nick repair pathways may result in apoptosis 
(37, 38, 45-49).     A c t i v a t i o n   o f   P A R P   h a s   b e e n   d e m o n-
strated to induce apoptosis in neuronal cells, to inter-
fere with the electron potential of the mitochondria, 
and to be required for the translocation of apoptosis 
inducing factor from the mitochondria to the nucleus 
(36-38, 45).   
T h e   f i n d i n g   t h a t   N S 1   i s   d i r e c t l y   ( A D P   r i-
bose)ylated  in  transfected  cells  provides  direct  evi-
dence  for  an  interaction  between  NS1  and  PARP.  
Since PARP is active at t h e   s i t e   o f   s i n g l e   s t r a n d   D N A  
breaks, and single-strand nicking is a known activity 
o f   N S 1   p r o t e i n ,   i t   i s   l i k e l y   t h a t   N S 1   i s   n i c k i n g   t h e   c e l-
l u l a r   D N A ,   t h e r e b y   i n d u c i n g   D N A   d a m a g e .     T h i s  
damage leads to apoptosis, as shown by decreased 
apoptosis  after  PARP  activity  was  inhibited  with 
5-aminoisoquinolinone. 
T h e   i m p o r t a n c e   o f   D N A   d a m a g e   t o   N S 1 -induced 
apoptosis is shown by the abrogation of apoptosis in 
the presence of inhibitors of DNA damage recognition 
enzymes.  Both the single strand nick repair pathway, 
m e d i a t e d   b y   P A R P ,   a n d   t h e   h e l i x -distorting damage 
r e p a i r   p a t h w a y s ,   m e d i a t e d   b y   A T M   o r   A T R ,   a r e   n e-
cessary for optimal induction of apoptosis induced by 
NS1  expression,  since  inhibition  of  these  pathways 
significantly decreases apoptosis in transfected cells.  
It  is  likely  that  NS1  additionally  uses  mechanisms 
o t h e r   t h a n   t h e   D N A   d a m a g e   r e p a i r   p a t h w a y s   s t u d i e d  
h e r e   t o   i n d u c e   a p o p t o s i s ,   g i v e n   t h a t   s o m e   l e v e l   o f  
apoptosis  persists  even  under  maximal  inhibitory 
conditions.  However, the degree of inhibition seen 
upon  administration  of  these  agents  indicates  that 
D N A   d a m a g e   i s   t h e   p r i m a r y   m e c h a n i s m   f o r  
NS1-induced apoptosis in these cells.  It is likely that 
N S 1   c a u s e s   c e l l   d e a t h   b y   a t   l e a s t   t w o   m e c h a n i s m s ,  
primarily  DNA  damage-induced  apoptosis  in 
non-permissive cells and through other mechanisms 
in permissive cells.   
These dual pathways correlate with differential 
viral  expression  in  these  cell  types.    In  permissive 
cells, all B19 genes are transcribed, while in nonper-
missive  cells  NS1 expression  predominates  (19,  50).  
N S 1   e x p r e s s i o n   l e a d s   t o   D N A   d a m a g e   i n   n o n p e r m i s-
sive  cells,  where  NS1  is  over  expressed,  while  the 
productive infection in permissive cells may lead to 
c e l l   d e a t h   b y   o t h e r   m e c h a n i s m s .     O n e   s u c h   m e t h o d   o f  
inducing  cell  death  is  through  TNF-α  induced  sig-
naling (51).  TNF-α   w a s   n o t   i n v o l v e d   i n   N S 1 -induced 
apoptosis of transfected HepG2 cells studied in our 
previous  work  (20).     O t h e r   m e c h a n i s m s   t h a t   a r e   r e-
sponsible for cell death in permissive parvovirus in-
fection  include  MVM  NS1  interactions  with  Casein 
Kinase II, resulting in cytoskeletal rearrangement and 
cell death (52, 53),   o r   t h e   g e n e r a t i o n   o f   r e a c t i v e   o x y g e n  
s p e c i e s   i n   r e s p o n s e   t o   D N A   d a m a g e   i n d u c e d   b y   H 1  
parvovirus NS1 protein (54).  Such mechanisms may 
c o n t r i b u t e   a l b e i t   t o   a   l e s s e r   d e g r e e   t h a n   d i r e c t   D N A  
d a m a g e   t o   t h e   a p o p t o s i s   s e e n   i n   t h e s e   c e l l s .     T h e   r e l a-
t i v e l y   s m a l l   n u m b e r   o f   c e l l s   k i l l e d   b y   N S 1   e x p r e s s i o n  
or B19 infection (approximately 1/3-1/2) can be ex-
p l a i n e d   i f   t h o s e   c e l l s   t h a t   d i e   a r e   t h o s e   t h a t   a r e   b o t h  
replicating  and  unable  to  adequately  repair  their 
DNA, while cells that can repair the damage survive.  
I f   N S 1   w e r e   d i r e c t l y   a c t i n g   o n   a p o p t o s i s -inducing 
factors, increased cytotoxicity would be anticipated. 
Single strand nicks are the type of DNA damage 
t h a t   w o u l d   b e   e x p e c t e d   f r o m   a   p a r v o v i r u s   n o n s t r u c-
tural protein that functions to separate the DNA rep-
licative form into individual genomes.  The process of 
n i c k i n g   b y   N S 1   i n   M V M   i s   h i g h l y   r e g u l a t e d ,   d e-
pending  on  both  cellular  factors,  such  as  RPA,  and 
recognition by NS1 of a specific DNA sequence (30, 




NS1-induced  apoptosis  of  hepatocytes  suggests  that 
either the DNA-nicking activity by NS1 protein of B19 
is not as highly regulated as in MVM, and so is able to 
pro c e e d   o n   c e l l u l a r   D N A ,   o r   t h a t   t h e r e   a r e   s i t e s   s u i t a-
b l e   f o r   N S 1   n i c k i n g   o n   t h e   c h r o m o s o m e s .     F u t u r e   s t u-
d i e s   a n a l y z i n g   t h e   s i t e   a t   w h i c h   N S 1   b i n d s   t o   t h e  
chromatin  should  demonstrate  the  NS1  binding  se-
quence.  
An appealing possibility suggested by the find-
in g   o f   N S 1 -DNA  attachment  concerns  the  develop-
ment of autoantibodies after B19 infection.  B19 infec-
t i o n   o f t e n   r e s u l t s   i n   t h e   p r o d u c t i o n   o f   a n t i -DNA au-
toantibodies (3, 4).     A   v i r a l   p r o t e i n ,   s u c h   a s   N S 1 ,   w i t h  
a   c o v a l e n t l y   l i n k e d   D N A   s t r a n d   c o u l d   s e r v e   a s   a  
hapten-c a r r i e r   s y s t e m .     I n   t h i s   m o d e l ,   a u t o r e a c t i v e   B  
cells  recognizing  DNA  in  a  DNA-protein  complex 
could internalize the complex, and  present  peptides 
d e r i v e d   f r o m   N S 1   t o   v i r u s -specific  T  cells.  
NS1-specific T cells, generated in the normal immune 
response  to  B19  (56),   c o u l d   t h e n   a c t i v a t e   t h e  
DNA-reactive  B-cells  that  present  NS1  peptides  on 
t h e i r   M H C   m o l e c u l e s ,   l e a d i n g   t o   t h e   d e v e l o p m e n t   o f  
a u t o a n t i b o d i e s .     D N A   a n d   h i s t o n e s   d o   i n   f a c t   b e c o m e  
i m m u n o g e n i c   w h e n   b o u n d   b y   t h e   l a r g e   T   a n t i g e n   o f  
polyomaviruses (57-60), a similar situation to   w h a t   w e  
envision  with  B19.    Antigen  presenting  cell  (APC) 
uptake  of  apoptotic  bodies  or  immune  complexes 
containing  NS1-  m o d i f i e d   D N A   w o u l d   a l l o w   A P C  
p r e s e n t a t i o n   o f   N S 1   p e p t i d e s   o n   t h e i r   M H C   a n d   a c t i-
vation of NS1-s p e c i f i c   T   c e l l s .     P a r v o v i r u s   B 1 9   m a y   b e  
an  example  of  a  virus  that  naturally  induces  an-
ti-DNA antibodies in this manner (Figure 4).   
This  testable  model  for  the  generation  of  au-
toantibodies in response to B19 infection is attractive 
i n   t h a t   i t   a s s u m e s   t h e   u t i l i z a t i o n   o f   T   c e l l s   t h a t   a r e  
specifi c   f o r   v i r a l   N S 1   p r o t e i n ,   a v o i d i n g   t h e   n e e d   f o r  
autoreactive  T  cells,  which  tend  to  be  tightly  regu-
l a t e d .     T   c e l l s   s p e c i f i c   f o r   N S 1   t h a t   a r e   a c t i v a t e d   i n   t h e  
immune response against B19 would be sufficient to 
a c t i v a t e   B   c e l l s   t o   i n i t i a t e   t h e   p r o d u c t i o n   o f   autoanti-
bodies.  Clinically, it is interesting when considering 
this model that patients with high titers of anti-NS1 
antibodies also are more likely to develop arthropa-
t h y ,   a   c o n d i t i o n   w h i c h   m a y   b e   a   r e s u l t   o f   a u t o a n t i-
body production (5, 61-63).     I n   a d d i t i o n   t o   N S 1 ,   i t   i s  
possible that autoimmune responses may be gener-
ated  to  other  nuclea r   p r o t e i n s   a s s o c i a t e d   w i t h   n u c-
leosomal DNA or NS1.   
 
F i g u r e   4 .   M o d e l   f o r   B 1 9   N S 1   i n d u c t i o n   o f   a n t i -DNA antibodies.  B19 induced apoptosis generates nucleosomes 
a n d   a p o p t o t i c   b o d i e s   c o n t a i n i n g   N S 1   m o d i f i e d   D N A .     A n e r g i z e d   anti-D N A   B   c e l l s   t a k e   u p   N S 1   m o d i f i e d   n u c l e o s o m a l   D N A  
through their anti-D N A   i m m u n o g l o b u l i n   s u r f a c e   r e c e p t o r   a n d   p r e s e n t   N S 1   p e p t i d e s   i n   t h e   c o n t e x t   o f   M H C   t o   N S 1 -specific 
T   c e l l s .     T h e   N S 1   s p e c i f i c   T   c e l l s   a r e   a c t i v a t e d   b y   A P C   t h a t   e x p r e s s   N S 1   p e p t i d e s   i n  t h e   c o n t e x t   o f   s u r f a c e   M H C   a f t e r   u p t a k e  
of apoptotic bodies or immune complexes containing NS1-m o d i f i e d   D N A     T h e   N S 1 -specific T cells provide the helper signal 
r e q u i r e d ,   i n   a d d i t i o n   t o   t h e   D N A   s i g n a l ,   f o r   t h e   a n e r g i z e d   B   c e l l   t o   b r e a k   t o l e r a n c e .     v D N A ,   v i ral DNA; hDNA, human DNA; 
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